Clinical Trial Update: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety of twice-daily oxycodone hydrochloride CR tablets for pediatric patients with moderate to severe pain requiring opioi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oxycodone hydrochloride controlled-release tablets (oxycodone hydrochloride controlled-release)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2015-02-06